Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00972621 · ClinicalTrials.gov registry record · NA

Clinical Evaluation of a New Viscoelastic for Cataract Surgery

A NA study, sponsored by Abbott Medical Optics.

Completed
Registry status
NA
Development phase
400
Enrollment target

NCT00972621: Completed NA study, sponsored by Abbott Medical Optics.

NCT00972621 is a NA study that has completed, run by Abbott Medical Optics. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00972621, a NA study, has completed, sponsored by Abbott Medical Optics.

COMPLETED
Registry status
NA
Development phase
400 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the safety and effectiveness of a new opthalmic viscoelastic material for the use in cataract surgery. The new viscoelastic will be compared to a currently marketed viscoelastic material.

Primary Outcome

Cumulative rate of Intraoperative Pressure (IOP) spikes 30 mm Hg (millimeters of mercury) or greater measured postoperatively through three months.

Interventions

  • DEVICE Vitrax II
  • DEVICE Viscoat

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2009-09-30
Est. Completion 2010-11-30
Phase NA
Abbott Medical Optics

14 total trials

What the finished NCT00972621 record still lists

NCT00972621 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).

The record links to 0 conditions, and to 2 interventions - of which Vitrax II is the first listed.

NCT00972621 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00972621 about?

NCT00972621 is a clinical study titled "Clinical Evaluation of a New Viscoelastic for Cataract Surgery". The purpose of this study is to evaluate the safety and effectiveness of a new opthalmic viscoelastic material for the use in cataract surgery. The new viscoelastic will be compared to a currently marketed viscoelastic material.

What is the current status of trial NCT00972621?

This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2009-09-30. Estimated completion is 2010-11-30.

What interventions are being tested in trial NCT00972621?

The interventions under investigation include: Vitrax II (DEVICE), Viscoat (DEVICE).

Who is sponsoring clinical trial NCT00972621?

This trial is sponsored by Abbott Medical Optics, which has 14 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00972621's enrollment target sits among peer trials

400 246th of 2000 higher than 1,734 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00972621, the US trial registry maintained by the National Library of Medicine. NCT00972621 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.